Fat accumulation in the liver, common in both non-drinkers (NAFLD, now MASLD) and those who consume alcohol (AFLD), may ...

Sagimet Biosciences (NASDAQ:SGMT) stock rises as Canaccord Genuity endorses the company's liver drug denifanstat as it launches coverage with a Buy. Read more here.

Altimmune's pemvidutide showed strong MASH resolution and good tolerability in IMPACT, but fibrosis data fell short. See why ...

A Virginia Commonwealth University (VCU) gastroenterologist and a global team of researchers have developed an artificial intelligence model that significantly improves doctors’ ability to predict ...

Alcohol-related liver disease has more than doubled in the U.S. over the last 20 years.

Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.

Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.

Background Steatotic liver disease-related hepatocellular carcinoma (SLD-HCC), a rising global challenge, is characterised by ...

Hepatitis and fatty liver disease, major causes of chronic liver injury, often present with subtle, easily overlooked ...

“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...

Provides Protection Through Sept. 2044; Will Be Listed in FDA’s Orange Book CONSHOHOCKEN, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical ...